XRP Healthcare Eyes TSXV Listing as Launchpad for Multibillion-Dollar Expansion

XRP Healthcare is progressing toward a proposed public listing on the TSX Venture Exchange (TSXV) a pivotal move in its strategy to modernize private healthcare across Africa through acquisitions, AI integration, and future licensing models.

Although the listing remains subject to final regulatory approval. XRP Healthcare has already crossed several significant milestones, including the signing of a Letter of Intent (LOI) and Definitive Agreement (DA) with AAJ Capital 3 Corp., corporate restructuring, legal preparation, and completion of audited financials.

This deliberate path to public markets underscores the company’s long-term mission: to close systemic gaps in healthcare delivery by combining physical infrastructure with scalable, tech-driven solutions. The TSXV, renowned for nurturing early-stage and high-growth companies, offers a regulatory platform aligned with XRP Healthcare’s goals transparency, scalability, and operational structure.

Laying the Groundwork: Strategic Acquisitions in Uganda

At the heart of XRP Healthcare’s expansion is its M&A-led model. With the successful acquisition of seven key pharmacy locations under the Pharma Ville banner. These include five wholesale depots and two retail pharmacies all in Uganda. A vital gateway to broader Sub-Saharan growth.

This acquisition cluster offers more than distribution capacity. It delivers community access points for essential medicines, localized health services, and future AI integrations. Uganda’s rising demand for affordable healthcare and favorable IP regulations make it an ideal launchpad for scaling the model continent-wide.

As integration progresses, XRP Healthcare is also evaluating new acquisition targets to expand its operational footprint while maintaining strong clinical and regulatory governance.

XRPH AI App: Bridging the Gap Between People and Care

In tandem with physical expansion, XRP Healthcare is rolling out the XRPH AI App a powerful, mobile-first digital health platform designed for accessibility in underserved regions.

Key Capabilities:

• Doctor Connect: Live feature enabling users to consult licensed professionals remotely.

• AI Health Support: Symptom-checking, health education, and early triage using locally relevant content and multilingual interfaces.

• Prescription Scanner: Offers clarity on medication use, side effects, and dosage through intuitive interpretation.

• U.S. Savings Card: Provides discounts at 68,000+ U.S. pharmacies, including Walmart, Walgreens, and CVS.

The XRPH AI App is live, growing, and localized, aiming to solve the fragmentation and inaccessibility. That plague many African healthcare systems. As smartphone penetration rises across the continent, XRPH AI is positioned to become a digital frontline for care.

Preparing for Scalable Licensing: A Next-Phase Growth Engine

As XRP Healthcare strengthens its brand, infrastructure, and digital assets, it is laying the legal and operational foundation for a scalable licensing program. This model will allow approved partners to operate under the XRP Healthcare brand, leveraging its technology and clinical standards without requiring the company to manage each location directly.

Strategic Benefits of Licensing:

• Faster Market Penetration across multiple regions

• Lower Capital Requirements, maximizing ROI

• Localized Operations led by regional experts

• Consistency and Oversight through a unified brand and tech platform

The synergy between acquisition, digital health, and licensing creates a growth model few in the African healthcare space can replicate offering rapid scalability while preserving quality and cost efficiency.

Positioning for Public Markets: A Milestone Quarter Ahead

XRP Healthcare is targeting its TSXV public listing for Q3 2025, with a proposed valuation of CAD $15 million. This step will not only boost investor confidence and improve access to global capital but also spotlight XRP Healthcare’s growing influence in Africa’s $259 billion healthcare market opportunity by 2030.

With advisory support from ARC Group, a global leader in IPO strategy, and progress across product, brand, and regulatory fronts, XRP Healthcare is positioning itself to become a defining force in private healthcare across emerging markets.

The Road Ahead: Scaling with Purpose and Precision

XRP Healthcare is not just expanding it is redefining what healthcare delivery can look like in underserved regions. By fusing real-world pharmacy infrastructure with cutting-edge AI and a future-forward licensing model. The company is building a healthcare ecosystem designed to scale with the needs of Africa’s growing populations.

The TSXV listing marks a strategic inflection point one that will propel XRP Healthcare’s ability to serve more people, attract global partners, and create sustainable, tech-driven impact at scale.

Forward-Looking Statement Disclaimer

This communication may contain “forward-looking statements” within the meaning of applicable securities laws. These statements involve known and unknown risks, uncertainties, and assumptions. That may cause actual results or developments to differ materially from those anticipated. XRP Healthcare undertakes no obligation to revise or update forward-looking statements except as required by law.